Alcon (ALC) Non-Current Deffered Revenue (2009 - 2010)
Alcon (ALC) posted quarterly Non-Current Deffered Revenue of $29.0 million for Q4 2010, little changed year-over-year from $29.0 million in Q4 2009, and little changed quarter-over-quarter from $29.0 million in Q4 2009.
Alcon (ALC) Non-Current Deffered Revenue (2009 - 2010) Analysis & Trends
Alcon's Non-Current Deffered Revenue history runs 2 years deep, the most recent figure standing at $29.0 million for Q4 2010.
- In Q4 2010, Non-Current Deffered Revenue changed 0.0% year-over-year to $29.0 million; the TTM figure through Dec 2010 stood at $29.0 million (changed 0.0% YoY), while the FY2010 annual figure was $29.0 million, changed 0.0% from the prior year.
- Non-Current Deffered Revenue for Q4 2010 stood at $29.0 million, roughly flat from $29.0 million in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $29.0 million in Q4 2009, with the low at $29.0 million in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 170.95 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 13.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 208.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 29.00 Mn |
| Dec 31, 2009 | 29.00 Mn |